Recruiting studies: Intensity Modulated Radiotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the L
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05354570 A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Br
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT05692674 Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherap
Phase 2 · 6 location(s) · University of Kansas Medical Center · NCT04992780 Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC
Phase 2 · 1 location(s) · Jianbin Bi · NCT06971211 PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT03907826 IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Phase N/A · 1 location(s) · Qiaojuan Guo · NCT07376603 Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
NA · 1 location(s) · Samsung Medical Center · NCT05453682 Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal C
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT04448522 Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06364579 Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma
NA · 1 location(s) · Zhongshan People's Hospital, Guangdong, China · NCT05994170 IMPT Dose Escalation for NSCLC (HyDose)
NA · 1 location(s) · University Medical Center Groningen · NCT06484491 Safety and Efficacy of IMPT or IMRT for Breast Cancer
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06826885 Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT03919552 Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operate
Phase 2 · 3 location(s) · Centre Paul Strauss · NCT05653622 Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carci
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT06611150 Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06306170 Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinom
Phase 3 · 12 location(s) · Ming-Yuan Chen · NCT07328841 Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
Phase 2 · 1 location(s) · Yongyi Zeng · NCT06349317 Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage B
Phase 3 · 5 location(s) · Rocky Mountain Cancer Centers · NCT01185132 Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
Phase 3 · 1 location(s) · Man Hu · NCT07340515 IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer
NA · 1 location(s) · Tata Memorial Centre · NCT06630793 Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT06802315 Xerostomia-optimised IMRT Versus Standard IMRT in NPC
NA · 1 location(s) · Zhongshan People's Hospital, Guangdong, China · NCT06282497 Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire UCLouvain Namur · NCT05611515 A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06485778 BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT04187105 Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanc
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06764680 Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07463833 Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Phase 3 · 1 location(s) · Yong Zhang,MD · NCT06017583 Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
NA · 2 location(s) · Tata Memorial Centre · NCT05857631

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.